Rice Hall James & Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-10,850
| Closed | -$393K | – | 312 |
|
|
2016
Q4 | $393K | Hold |
10,850
| – | – | 0.02% | 273 |
|
|
2016
Q3 | $499K | Hold |
10,850
| – | – | 0.03% | 255 |
|
|
2016
Q2 | $545K | Sell |
10,850
-300
| -3% | -$15.1K | 0.03% | 254 |
|
|
2016
Q1 | $597K | Hold |
11,150
| – | – | 0.03% | 247 |
|
|
2015
Q4 | $732K | Hold |
11,150
| – | – | 0.04% | 247 |
|
|
2015
Q3 | $630K | Hold |
11,150
| – | – | 0.04% | 256 |
|
|
2015
Q2 | $659K | Hold |
11,150
| – | – | 0.04% | 259 |
|
|
2015
Q1 | $695K | Hold |
11,150
| – | – | 0.04% | 262 |
|
|
2014
Q4 | $641K | Hold |
11,150
| – | – | 0.04% | 260 |
|
|
2014
Q3 | $599K | Hold |
11,150
| – | – | 0.04% | 252 |
|
|
2014
Q2 | $584K | Sell |
11,150
-200
| -2% | -$10.5K | 0.04% | 260 |
|
|
2014
Q1 | $600K | Hold |
11,350
| – | – | 0.04% | 252 |
|
|
2013
Q4 | $455K | Buy |
11,350
+400
| +4% | +$16K | 0.03% | 262 |
|
|
2013
Q3 | $414K | Hold |
10,950
| – | – | 0.04% | 240 |
|
|
2013
Q2 | $429K | Buy |
+10,950
| New | +$429K | 0.04% | 230 |
|